Markus Bredemeier
Porto Alegre, RS, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
2023 Brazilian Society of Rheumatology guidelines for the treatment of systemic sclerosis.
Journal: Advances in rheumatology (London, England)
Published: September 30, 2023
The effect of antimalarials on the safety and persistence of treatment with biologic agents or Janus kinase inhibitors in rheumatoid arthritis.
Journal: Rheumatology (Oxford, England)
Published: January 04, 2023
A destructive nasal skin lesion caused by fungal infection in a systemic lupus erythematosus patient.
Journal: Clinical rheumatology
Published: November 18, 2022
Physical frailty in patients with systemic sclerosis.
Journal: Seminars in arthritis and rheumatism
Published: April 26, 2022
Treatment with biological therapy is associated with faster recovery and lower frequency of treatment switch among rheumatic patients with Chikungunya fever.
Journal: Advances in rheumatology (London, England)
Published: February 16, 2022
Safety of the Methotrexate-leflunomide Combination in Rheumatoid Arthritis: Results of a Multicentric, Registry-based, Cohort Study (BiobadaBrasil).
Journal: The Journal of rheumatology
Published: January 02, 2022
A Simple Double-Spin Closed Method for Preparing Platelet-Rich Plasma.
Journal: Cureus
Published: January 01, 2022
Personalized multitarget biologic injection in the spine: prospective case series of multitarget platelet-rich plasma for low back pain.
Journal: Regenerative medicine
Published: December 15, 2021
Effects of a physical self-care support program for patients with fibromyalgia: A randomized controlled trial.
Journal: Journal of back and musculoskeletal rehabilitation
Published: October 18, 2021
Additional points to consider before incorporating the Food and Drug Administration-approved therapies for systemic sclerosis-associated interstitial lung disease: comment on the article by Khanna et al.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: September 14, 2021
Safety of the Methotrexate-leflunomide Combination in Rheumatoid Arthritis: Results of a Multicentric, Registry-based, Cohort Study (BiobadaBrasil).
Journal: The Journal of rheumatology
Published: April 20, 2021
Clinical and Methodologic Considerations With Regard to a Trial of Nintedanib in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Comment on the Reanalysis by Maher et al.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: April 10, 2021
Last Updated: 09/26/2026